Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-15 Sale |
2021-03-16 7:45 pm |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
22,912 | $6.9151 | $158,440 | 122,746 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-15 Exercise |
2021-03-16 7:45 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
12,000 | $3.31 | 122,746 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-16 7:45 pm |
N/A 2030-02-06 |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
12,000 | $0 | 122,746 (Direct) |
View |
| 2021-02-28 Tax Withholding |
2021-03-02 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
10,765 | $7.19 | 119,508 (Direct) |
View |
| 2021-02-28 Exercise |
2021-03-02 5:00 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
28,316 | $0 | 119,508 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 4:16 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Tessmer James F VP, Finance & Accounting |
40,570 | $0 | 40,570 (Direct) |
View |